MENINGOCOCCAL GROUP

Contract SPE2DP26P0967 was awarded on June 30, 2026, by the Defense Logistics Agency Troop Support Medical Supply Chain Pharm FSA to DMS Pharmaceutical Group Inc, a small disadvantaged and women-owned small business. The order was for the procurement of Meningococcal Group vaccines, specifically Sanofi Vaccines US Inc part number NDC 49281-0590-10, with an original total value of 1,559.54 dollars, including federal excise tax. The contract specified strict medical handling requirements, including shipping via the Medical Air Bridge and maintaining a refrigerated temperature range of 2C to 8C. Packaging and marking were required to comply with MIL-STD-2073-1E and Medical Marking Standard No. 1, with delivery and acceptance set for destination. The contract included rigorous cybersecurity and administrative mandates, requiring compliance with NIST SP 800-171 Rev. 2 and the reporting of cyber incidents within 72 hours per DFARS 252.204-7012. All invoicing and payment requests were required to be processed through the Wide Area WorkFlow system. However, on July 1, 2026, modification P00001 was issued as a supplemental agreement for termination for the government's convenience. This modification cancelled the line items for the vaccines and excise tax due to a duplicate requisition, effectively reducing the total contract value to 0.00 dollars.